Neurocrine Biosciences Aktie
148,65
EUR
+1,95
EUR
+1,33
%
153,29
USD
-0,06
USD
-0,04
%
Werbung
Neurocrine Biosciences Aktie Analyse
14.12.07 | Neurocrine Biosciences underperform | Bear Stearns Companies Inc. | |
14.12.07 | Neurocrine Biosciences sell | Piper Jaffray & Co. | |
14.12.07 | Neurocrine Biosciences underperform | Jefferies & Company Inc. | |
29.06.06 | Neurocrine Biosciences reduce | UBS | |
23.06.06 | Neurocrine Biosciences underweight | Morgan Stanley | |
23.06.06 | Neurocrine Biosciences sell | Citigroup | |
16.06.06 | Neurocrine Biosciences underperform | Leerink Swann | |
16.06.06 | Neurocrine Biosciences underperform | Robert W. Baird | |
Werbung
|
|||
16.06.06 | Neurocrine Biosciences Underperform | Leerink Swann | |
18.05.06 | Neurocrine Biosciences underperform | Jefferies & Co |
Werbung
Werbung